Gain Therapeutics, Inc.
GANX
$1.71
-$0.04-2.29%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -60.47% | -28.36% | -38.16% | -1.50% | 4.59% |
| Total Receivables | 351.53% | 255.92% | 215.66% | 266.73% | 94.90% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -7.06% | 25.38% | -39.20% | 45.36% | 35.06% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -49.80% | -19.56% | -34.74% | 3.77% | 7.11% |
|
|
|||||
| Total Current Assets | -49.80% | -19.56% | -34.74% | 3.77% | 7.11% |
| Net Property, Plant & Equipment | -26.77% | -43.32% | -44.75% | -35.10% | -35.59% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -19.10% | -25.35% | -30.56% | -17.39% | -22.69% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 41.70% | 31.98% | 22.93% | 37.94% | -0.40% |
| Total Assets | -48.77% | -20.26% | -34.85% | 1.90% | 5.12% |
|
|
|||||
| Total Accounts Payable | 32.55% | 53.10% | -28.26% | -20.22% | 121.42% |
| Total Accrued Expenses | -36.41% | 3.72% | 14.77% | -5.83% | 11.62% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -11.92% | -16.99% | -22.21% | -12.72% | -14.25% |
| Total Finance Division Other Current Liabilities | -93.69% | -76.17% | -76.88% | -48.76% | -39.41% |
| Total Other Current Liabilities | -93.69% | -76.17% | -76.88% | -48.76% | -39.41% |
| Total Current Liabilities | -20.33% | 0.49% | -20.98% | -20.28% | 16.73% |
|
|
|||||
| Total Current Liabilities | -20.33% | 0.49% | -20.98% | -20.28% | 16.73% |
| Long-Term Debt | -13.32% | -20.74% | -26.90% | -13.52% | -19.55% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -30.83% | -82.75% | -76.69% | -63.49% | -59.32% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 37.99% | 31.98% | 22.10% | 27.62% | -51.63% |
| Total Liabilities | -17.18% | -1.53% | -20.67% | -19.37% | 3.40% |
|
|
|||||
| Common Stock & APIC | 11.73% | 24.80% | 21.43% | 36.01% | 35.98% |
| Retained Earnings | -25.49% | -32.30% | -33.58% | -38.11% | -42.07% |
| Treasury Stock & Other | 4,572.80% | -647.49% | -200.12% | 167.70% | -90.69% |
| Total Common Equity | -68.64% | -33.12% | -41.65% | 21.53% | 6.24% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -68.64% | -33.12% | -41.65% | 21.53% | 6.24% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -68.64% | -33.12% | -41.65% | 21.53% | 6.24% |
|
|
|||||